Science Explorer Interactive view Map
Company · Stony Brook · United States

Codagenix (United States)

codagenix.comROR OpenAlex
Research works
19
▲ 448% vs 2013–17
Citations
311
16.7 per fractional work
Top-10% rate
10.9%
record average 16.5%
Open access
71%
world 28%

Not ranked overall: Codagenix (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.28× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.79× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 13.85× its world share, 1 worksImmunology and Micro…Computer Science: 0.59× its world share, 0 worksComputer ScienceEngineering: 0.35× its world share, 0 worksEngineeringEnvironmental Science: 0.40× its world share, 0 worksEnvironmental ScienceMedicine: 2.12× its world share, 3 worksMedicineSocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.8×. Every wedge is a field page.

Which research topics does Codagenix (United States) publish most on?

By volume in 2022–2025: Cancer Research and Treatments, Virus-based gene therapy research, Virology and Viral Diseases and Mosquito-borne diseases and control.

Cancer Research and Trea…1Cancer Research and Treatments: 1 fractional worksVirus-based gene therapy…1Virus-based gene therapy research: 1 fractional worksVirology and Viral Diseases: 1 fractional worksMosquito-borne diseases and control: 0 fractional worksinterferon and immune responses: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksBiosensors and Analytical Detection: 0 fractional works
BiotechnologyGeneticsEpidemiologyPublic Health, Environmental and Occupational Health4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Research and Treatments Biotechnology 1 works
  2. 2 Virus-based gene therapy research Genetics 1 works
  3. 3 Virology and Viral Diseases Epidemiology 1 works
  4. 4 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
  5. 5 interferon and immune responses Immunology 0 works
  6. 6 CAR-T cell therapy research Oncology 0 works
  7. 7 Immunotherapy and Immune Responses Immunology 0 works
  8. 8 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  9. 9 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  10. 10 Biosensors and Analytical Detection Biomedical Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.4%not open28.6%

World: 28% of research is openly available.

with international co-authors18.4%domestic only81.6%

World: 19% is written across borders.

How has Codagenix (United States)'s research output changed?

Output in 2018–2022 was 448% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Stony Brook

All research institutions in Stony Brook

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.